Do you suffer from resistant hypertension?
This clinical research study is looking at the safety and effectiveness of a medication for people with resistant hypertension. This is a Phase 3 trial to evaluate the blood pressure lowering effect of lorundrostat in subjects with uncontrolled and resistant hypertension, who are also taking between 2 and 5 anti-hypertensive (AHT) medications.
Would you like to take part?
As a volunteer in a research study, you’ll receive study-related medical care from the study doctor and regular follow-up of your hypertension to monitor the effectiveness of the care you’ll receive. The results of this research will be used to find out if the investigational medication being studied will be of benefit to others with resistant hypertension, and whether it will be made widely available to all patients with hypertension. Study volunteers are an important part of moving medical care forward.
You may qualify to participate in this study if you:
- Are 18 years of age or older at the time of signing informed consent
- Are taking between 2-5 anti-hypertension medications
- Have a history of hypertension lasting at least 6 months prior to Screening
- Have a body mass index (BMI) of ≥18 kg/m2 at Screening
You may not qualify to participate if you:
- Are pregnant, or plan to become pregnant during the duration of the study
- Have participated in a study involving any investigational device or small-molecule drug within 4 weeks or 6 months for biologic (antibody) drugs prior to the Screening Visit
- Have a history of heart failure, myocardial infarction, stroke, or transient ischemic attack within 6 months prior to the Screening Visit.
There are other eligibility requirements that the study doctor will review. Only the study doctor can finally determine whether you are eligible to participate in the study or not.
